halofuginone has been researched along with Candidiasis, Vulvovaginal in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bistoni, F; d'Enfert, C; Mosci, P; Pandey, N; Pietrella, D; Pines, M; Rachini, A; Vecchiarelli, A | 1 |
1 other study(ies) available for halofuginone and Candidiasis, Vulvovaginal
| Article | Year |
|---|---|
Th17 cells and IL-17 in protective immunity to vaginal candidiasis.
Topics: Animals; beta-Defensins; Candida albicans; Candidiasis, Vulvovaginal; Disease Models, Animal; Female; Immunity; Interleukin-17; Interleukin-23; Lymph Nodes; Mice; Neutrophil Infiltration; Piperidines; Quinazolinones; Th17 Cells; Vagina | 2011 |